Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Operating Leases (2024 - 2026)

Carlsmed filings provide 2 years of Operating Leases readings, the most recent being $1.3 million for Q4 2025.

  • On a quarterly basis, Operating Leases changed 0.08% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 million, a 0.08% change, with the full-year FY2025 number at $1.3 million, changed 0.08% from a year prior.
  • Operating Leases hit $1.3 million in Q4 2025 for Carlsmed, down from $1.5 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $1.7 million in Q2 2025 to a low of $1.3 million in Q4 2025.